Awarded Research Grants

 

Study Name Researcher Instituion Amount
2019
Distinction of Serum Biomarkers of Heart Failure Between Children and Adults with Dilated Cardiomyopathy Kathleen E. Simpson, MD Washington University in Saint Louis, Saint Louis, MO $24,400
       
2018
Immunologic Profiling Correlated to Outcomes in Pediatric Heart Failure Patients After Left Ventricular Assist Device Placement Meghna D Patel, MD
Daniel Bernstein, MD
Gregory Hammer, MD
Stanford University, Palo Alto, CA $50,000

Modeling Novel Therapeutics for DCMA, a Mitochondrial Cardiomyopathy Steven Greenway, MD University of Calgary, Alberta, Canada $49,184

Elucidating the Genetics of Myocarditis-Related Cardiomyopathy Amy Kontorovich, MD, PhD Icahn School of Medicine at Mount Sinai, New York, NY $50,000

Circulating MicroRNA in Genotype-Positive Hypertrophic Cardiomyopathy Shelley Miyamoto, MD
Carolyn Ho, MD
Kika Sucharov, PhD
University of Colorado, Denver, CO $50,000

Distinction of Serum Biomarkers of Heart Failure Between Children and Adults with Dilated Cardiomyopathy Kathleen E. Simpson, MD Washington University in Saint Louis, Saint Louis, MO $46,988
       
2017
Human Induced Pluripotent Stem Cell Model of Hypertrophic Cardiomyopathy Teresa M. Lee, MD, MS
Masayuki Yazawa, PhD
Columbia University, New York, NY $50,000

Impact of Genetic Testing For Cardiomyopathies on Children and Their Families Wendy Chung, MD, PhD Columbia University, New York, NY $50,000
       
2016
Integrated Family-Centered Behavioral Health Screening & Preventive Intervention for Pediatric Cardiomyopathy Juan Alejos, MD
Patricia Lester, MD
University of California, Los Angeles, CA $50,000

The Role of GSK3β in the Pathogenesis of Arrhythmogenic Cardiomyopathy Angeliki Asimaki, PhD Beth Israel Deaconess Medical Center, Boston, MA $50,000

Genetic Analysis to Identify Inheritance Patterns in Histiocytoid Cardiomyopathy Bahig M. Shehata, MD Emory University School of Medicine, Atlanta, GA $49,552

Targeting Membrane Repair to Treat Pediatric Dilated Cardiomyopathy Noah Weisleder, PhD Ohio State University, Columbus, OH $50,000
       
2015
Automated ECG Screening for Hypertrophic Cardiomyopathy Richard J. Czosek, MD Cincinnati Children’s Hospital Medical Center, Cincinnati, OH $28,200

Disease Pathways for MYBPC3 Mutations in Hypertrophic Cardiomyopathy Sharlene Day, MD University of Michigan, Ann Arbor, MI $50,000

Visual Proteomics for Personalized Assessment of Risk in ARVC Families Mario Delmar, MD, PhD New York University School of Medicine, New York, NY $50,000

Influence of Pediatric Cardiomyopathy on Health Related Quality of Life Kristi Glotzbach, MD Albert Einstein College of Medicine, Bronx, NY $50,000

Prevalence and Evolution of Late Gadolinum Enhancement and Myocardial Hypertrophy in Childhood Cardiomyopathy Lars Gross-Wortmann, MD The Hospital for Sick Children, Toronto, Canada $46,918

Mechanism of RAF1 Mediated Pediatric Hypertrophic Cardiomyopathy Abdur Razzaque, PhD University of Wisconsin, Madison, WI $48,000
       
2014
Cardiovascular Magnetic Resonance Assessment of Diffuse Myocardial Fibrosis in Hypertrophic Cardiomyopathy Timothy Wong, MD University of Pittsburgh $308,000

iPSC-Derived Cardiomyocytes in Left Ventricular Non-Compaction Cardiomyopathy Daniel Bernstein, MD Stanford University, Palo Alto, CA $50,000

Late INa Contributes to Diastolic Dysfunction in Hypertrophic Cardiomyopathy David Fedida, PhD University of British Columbia, Vancouver, Canada $50,000

Translational Proteomics in Hypertrophic Cardiomyopathy Anne M. Murphy, MD Johns Hopkins University, Baltimore, MD $50,000

Pak1 as a Target for New Treatment of Hypertrophic Cardiomyopathy Beata M. Wolska, PhD University of Illinois, Chicago, IL $50,000
       
2013
Developmental Effects of PTPN11 Mutations on Pediatric Hypertrophic Cardiomyopathy Maria I. Kontaridis, PhD Beth Israel Deaconess Medical Center, Boston, MA $50,000

Pediatric Hypertrophic Cardiomyopathy Caused by Myosin Mutations Leslie A. Leinwand, PhD University of Colorado, Boulder, CO $45,837

Human IPS Cells and ECT in the Study of Hypertrophic Cardiomyopathy John Carter Ralphe, MD University of Wisconsin, Madison, WI $50,000
       
2012
Drivers of Pediatric Dilated Cardiomyopathy Daniela Cihakova, MD, PhD Johns Hopkins University, Baltimore, MD $50,000

Patterns and Clinical Significance of Electro-mechanical Dyssynchrony in Pediatric Dilated Cardiomyopathy Mark K. Friedberg, MD Hospital for Sick Children, Toronto, Canada $44,550

MicroRNA Expression In Children with Heart Failure Carmen (Kika) Sucharov, PhD University of Colorado, Denver, CO $50,000
       
2011
Identification of New Genes for Infantile Cardiomyopathy Wendy Chung, MD, PhD Columbia University, New York, NY $100,000

Informing Diagnostic and Prognostic Information For Arrhythmogenic Right Ventricular Cardiomyopathy Type 5 (ARVD5) In Children By Comprehensive Clinical and Genetic Analysis Kathy Hodgkinson, PhD Memorial University of Newfoundland, NL, Canada $49,645

Expanding the Donor Pool for Pediatric Heart Transplant Carmelo Milano, MD Duke University, Durham, NC $50,000

Development of a Model System for Tropomyosin-linked Early Onset Dilated Cardiomyopathy Jil Tardiff, MD, PhD Albert Einstein College of Medicine, Bronx, NY $50,000
       
2010
Genes and Modifiers in Pediatric Cardiomyopathy Stephanie Ware, MD, PHD Cincinnati Children's Hospital, Cincinnati, OH $86,735 

Characterizing Molecular Mechanisms of Cardiomyocyte Proliferation Aimed at Developing New Regenerative Therapies of Cardiomyopathy Bernhard Kuhn, MD Children's Hospital Boston $50,000

3D Engineered Cardiac Tissue: A Novel Tool to Unravel Genotype/Phenotype Relationships in MYBPC3 - Associated Childhood Hypertrophic Cardiomyopathy J. Carter Ralphe, MD University of Wisconsin, Madison, WI $50,000 
       
2009
Delineating Autoimmunity in Postinfectious Myocarditis Jay Reddy, DVM, PhD University of Nebraska, Lincoln, NE $308,000

Comparative Analysis of Human iPS Cells to Generate Vascularized Cardiac Tissue Constructs Charles Murry, MD, PhD University of Washington, Seattle, WA $50,000
       
2008
Calcium Channel Disruption: A New Model of Non-Compaction Cardiomyopathy George Porter, MD Yale University, New Haven, CT $198,000

Development of a Novel Resequencing Chip to Diagnose Pediatric Cardiomyopathy Stephanie Ware, MD, PhD Cincinnati Children's Hospital, Cincinnati, OH $49,750

Effects of ACE Inhibitors and Beta-blockers on Cardiac Function in Murine Models of Inherited Dilated Cardiomyopathy due to Mutations in the Nebulette Gene Enkhsaikhan Purevjav, MD, PhD Baylor College of Medicine, Houston, TX $45,000

Hypertrophic Cardiomyopathy
and RAS-MAP Kinase Signaling
Bruce D. Gelb, MD Mount Sinai School of Medicine, New York, NY $49,587

The Role of MuRF1 in MyBP-c Turnover and Its Effects on Cardiac Energy Metabolism in Familial Hypertrophic Cardiomyopathy Monte S. Willis, MD, PhD University of North Carolina, Chapel Hill, NC $50,000
       
2007
Extracellular Mechanisms in Pediatric Cardiomyopathy Tain-Yen Hsia, MD Medical University of South Carolina, Charleston, SC $50,000

Outcome of pediatric patients with cardiomyopathy: a multi-centre review of pediatric patients listed for transplant in the Pediatric Heart Transplant Study Anne I. Dipchand, MD Hospital for Sick Children, Toronto, Canada $42,642
       
2006
Identification of Mutations in Genes Associated with Hypertrophic Cardiomyopathy and Dilated Cardiomyopathy Jeffrey A. Towbin, MD Baylor College of Medicine, Houston, TX $92,250

Exercise Intervention in a Pediatric Population with Cardiomyopathy Tracie Miller, MD University of Miami, Miami, FL $45,000
       
2005
Involvement of Cypher Specific Isoforms in Dilated Cardiomyopathy Ju Chen, PhD University of California, San Diego, CA $50,000

Analysis of Sarcomere Gene Mutations in Pediatric Hypertrophic Cardiomyopathy Gerald F. Cox, MD, PhD Children's Hospital, Boston, MA  $60,000
       
2004
RAAS Gene Polymorphisms Influence Cardiac Remodeling in Children with Hypertrophic Cardiomyopathy Seema Mital, MD, FACC Children's Hospital of New York-Presybyterian, New York, NY $25,000
       
2003
Baseline Predictors of Outcome
in Children with Cardiomyopathy
Steve Lipshultz, MD University of Rochester, Rochester, NY $30,000
       
2002
Molecular Genetic Stratification of Familial Hypertrophic Cardiomyopathy Wendy Chung, MD, PhD Columbia University, New York, NY $45,000
       
       

 

Stay Informed
Keep current on PCM research and CCF happenings in our Heart to Heart newsletter.
Unite and Fight
Connect with hundreds of other families struggling with this disease through our online member community.
Shop for a Cure
Shop for CCF merchandise to support our research and education efforts.
The Children's Cardiomyopathy Foundation is a 501 (c)(3) non-profit recognized by the U.S. Internal Revenue Service.
© 2018 Children's Cardiomyopathy Foundation. All rights reserved.